BIOMAT Database Logo BIOMAT Database Logo

Design, Synthesis, and Biological Evaluation of Imidazo[1,2-a]pyridine Derivatives as Novel PI3K/mTOR Dual Inhibitors. 2020

Ya'nan Yu, and Yuqiao Han, and Fupo Zhang, and Zhenmei Gao, and Tong Zhu, and Suzhen Dong, and Mingliang Ma
Shanghai Engineering Research Center of Molecular Therapeutics and New Drug Development, School of Chemistry and Molecular Engineering, East China Normal University, Shanghai 200062, P. R. China.

PI3K-Akt-mTOR signaling pathway has been validated as an effective targeting pathway for cancer therapy. However, no PI3K/mTOR dual inhibitor has been approved by the FDA yet. Therefore, it is still essential to discover a candidate with good efficacy and low toxicity. In our design, a series of imidazo[1,2-a]pyridine derivatives had been synthesized and subjected to activity assessment in vitro and in vivo. 15a was proved to be a potent PI3K/mTOR dual inhibitor with excellent kinase selectivity, modest plasma clearance, and acceptable oral bioavailability. Besides, 15a displayed significant inhibition of tumor growth in HCT116 and HT-29 xenografts without obvious effect on body weight.

UI MeSH Term Description Entries
D007093 Imidazoles Compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons. Chemically reduced ones include IMIDAZOLINES and IMIDAZOLIDINES. Distinguish from 1,2-diazole (PYRAZOLES).
D008297 Male Males
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D008819 Mice, Nude Mutant mice homozygous for the recessive gene "nude" which fail to develop a thymus. They are useful in tumor studies and studies on immune responses. Athymic Mice,Mice, Athymic,Nude Mice,Mouse, Athymic,Mouse, Nude,Athymic Mouse,Nude Mouse
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D011725 Pyridines Compounds with a six membered aromatic ring containing NITROGEN. The saturated version is PIPERIDINES.
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000081082 Phosphoinositide-3 Kinase Inhibitors Agents that inhibit PHOSPHOINOSITIDE-3 KINASE activity. Phosphoinositide-3 Kinase Inhibitor,Inhibitor, Phosphoinositide-3 Kinase,Inhibitors, Phosphoinositide-3 Kinase,Kinase Inhibitor, Phosphoinositide-3,Kinase Inhibitors, Phosphoinositide-3,Phosphoinositide 3 Kinase Inhibitor,Phosphoinositide 3 Kinase Inhibitors
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Ya'nan Yu, and Yuqiao Han, and Fupo Zhang, and Zhenmei Gao, and Tong Zhu, and Suzhen Dong, and Mingliang Ma
Design, Synthesis and Biological Evaluation of Imidazo[1,2-a]pyridine Derivatives as Novel DPP-4 Inhibitors.
October 2015, Chemical biology & drug design,
Ya'nan Yu, and Yuqiao Han, and Fupo Zhang, and Zhenmei Gao, and Tong Zhu, and Suzhen Dong, and Mingliang Ma
Design, Synthesis, and Biological Evaluation of Novel Imidazo[1,2-a]pyridine Derivatives as Potent c-Met Inhibitors.
May 2015, ACS medicinal chemistry letters,
Ya'nan Yu, and Yuqiao Han, and Fupo Zhang, and Zhenmei Gao, and Tong Zhu, and Suzhen Dong, and Mingliang Ma
Design, Synthesis and Biological Evaluation of Novel Phenylsulfonylurea Derivatives as PI3K/mTOR Dual Inhibitors.
June 2018, Molecules (Basel, Switzerland),
Ya'nan Yu, and Yuqiao Han, and Fupo Zhang, and Zhenmei Gao, and Tong Zhu, and Suzhen Dong, and Mingliang Ma
Design, synthesis, and biological evaluation of imidazo[1,2-b]pyridazine derivatives as mTOR inhibitors.
March 2017, European journal of medicinal chemistry,
Ya'nan Yu, and Yuqiao Han, and Fupo Zhang, and Zhenmei Gao, and Tong Zhu, and Suzhen Dong, and Mingliang Ma
Design, Synthesis, and Biological Evaluation of Sulfonamide Methoxypyridine Derivatives as Novel PI3K/mTOR Dual Inhibitors.
March 2023, Pharmaceuticals (Basel, Switzerland),
Ya'nan Yu, and Yuqiao Han, and Fupo Zhang, and Zhenmei Gao, and Tong Zhu, and Suzhen Dong, and Mingliang Ma
Synthesis and biological evaluation of imidazo[1,2-a]pyridine derivatives as novel PI3 kinase p110alpha inhibitors.
January 2007, Bioorganic & medicinal chemistry,
Ya'nan Yu, and Yuqiao Han, and Fupo Zhang, and Zhenmei Gao, and Tong Zhu, and Suzhen Dong, and Mingliang Ma
Design, synthesis and biological evaluation of novel 4-alkynyl-quinoline derivatives as PI3K/mTOR dual inhibitors.
June 2015, European journal of medicinal chemistry,
Ya'nan Yu, and Yuqiao Han, and Fupo Zhang, and Zhenmei Gao, and Tong Zhu, and Suzhen Dong, and Mingliang Ma
Design, synthesis and biological evaluation of novel morpholinopyrimidine-5-carbonitrile derivatives as dual PI3K/mTOR inhibitors.
February 2024, RSC medicinal chemistry,
Ya'nan Yu, and Yuqiao Han, and Fupo Zhang, and Zhenmei Gao, and Tong Zhu, and Suzhen Dong, and Mingliang Ma
Structure-based design, synthesis, and evaluation of imidazo[1,2-b]pyridazine and imidazo[1,2-a]pyridine derivatives as novel dual c-Met and VEGFR2 kinase inhibitors.
December 2013, Bioorganic & medicinal chemistry,
Ya'nan Yu, and Yuqiao Han, and Fupo Zhang, and Zhenmei Gao, and Tong Zhu, and Suzhen Dong, and Mingliang Ma
Design, synthesis, and biological evaluation of novel 3-substituted imidazo[1,2-a]pyridine and quinazolin-4(3H)-one derivatives as PI3Kα inhibitors.
October 2017, European journal of medicinal chemistry,
Copied contents to your clipboard!